144 related articles for article (PubMed ID: 16911391)
21. Pustular psoriasis following treatment of rheumatoid arthritis with TNF-alpha inhibitors.
Egnatios G; Warthan MM; Pariser R; Hood AF
J Drugs Dermatol; 2008 Oct; 7(10):975-7. PubMed ID: 19112764
[No Abstract] [Full Text] [Related]
22. Graves' disease, rheumatoid arthritis, and anti-tumor necrosis factor-alpha therapy.
Shin JI; Kim MJ; Lee JS
J Rheumatol; 2009 Feb; 36(2):449-50; author reply 450. PubMed ID: 19208577
[No Abstract] [Full Text] [Related]
23. Psoriatic lesions induced by antitumour necrosis factor-alpha treatment: two cases.
Dereure O; Guillot B; Jorgensen C; Cohen JD; Combes B; Guilhou JJ
Br J Dermatol; 2004 Aug; 151(2):506-7. PubMed ID: 15327565
[No Abstract] [Full Text] [Related]
24. Guillain-Barré syndrome in a patient receiving anti-tumour necrosis factor alpha for rheumatoid arthritis: a case report and discussion of literature.
Silburn S; McIvor E; McEntegart A; Wilson H
Ann Rheum Dis; 2008 Apr; 67(4):575-6. PubMed ID: 18349168
[No Abstract] [Full Text] [Related]
25. Is it safe to readminister tumor necrosis factor alpha antagonists following tuberculosis flare?
Aslanidis S; Pyrpasopoulou A; Douma S; Petidis K
Arthritis Rheum; 2008 Jan; 58(1):327-8. PubMed ID: 18163500
[No Abstract] [Full Text] [Related]
26. Unexpected onset of psoriasis during infliximab treatment: comment on the article by Beuthien et al.
Grinblat B; Scheinberg M
Arthritis Rheum; 2005 Apr; 52(4):1333-4; author reply 1334. PubMed ID: 15818679
[No Abstract] [Full Text] [Related]
27. Pseudolymphomatoid cutaneous leishmaniasis in a patient treated with adalimumab for rheumatoid arthritis.
Baltà-Cruz S; Alsina-Glbert M; Mozos-Rocafort A; Cervera C; Colomo-Saperas L; Del Río A; Estrach-Panella T
Acta Derm Venereol; 2009; 89(4):432-3. PubMed ID: 19688168
[No Abstract] [Full Text] [Related]
28. Adalimumab-induced acute pneumonitis in a patient with rheumatoid arthritis.
Dascalu C; Mrejen-Shakin K; Bandagi S
J Clin Rheumatol; 2010 Jun; 16(4):172-4. PubMed ID: 20511978
[TBL] [Abstract][Full Text] [Related]
29. New drugs for rheumatoid arthritis.
Olsen NJ; Stein CM
N Engl J Med; 2004 May; 350(21):2167-79. PubMed ID: 15152062
[No Abstract] [Full Text] [Related]
30. The enigmatic development of psoriasis and psoriasiform lesions during anti-TNF therapy: a review.
Grinblat B; Scheinberg M
Semin Arthritis Rheum; 2008 Feb; 37(4):251-5. PubMed ID: 17640718
[TBL] [Abstract][Full Text] [Related]
31. Anti-tumor necrosis factor-alpha-induced psoriasis.
Sari I; Akar S; Birlik M; Sis B; Onen F; Akkoc N
J Rheumatol; 2006 Jul; 33(7):1411-4. PubMed ID: 16821276
[TBL] [Abstract][Full Text] [Related]
32. Anti-tumor necrosis factor-alpha agents for rheumatoid arthritis: assessing longterm safety.
Hyrich KL; Silman AJ
J Rheumatol; 2006 May; 33(5):831-3. PubMed ID: 16652412
[No Abstract] [Full Text] [Related]
33. New-onset psoriatic palmoplantaris pustulosis following infliximab therapy: a class effect?
Roux CH; Brocq O; Leccia N; Giacchero D; Breuil V; Albert C; Lacour J; Perrin C; Euller-Ziegler L
J Rheumatol; 2007 Feb; 34(2):434-7. PubMed ID: 17295430
[TBL] [Abstract][Full Text] [Related]
34. Clinical trials. Gene transfer an unlikely contributor to patient's death.
Kaiser J
Science; 2007 Dec; 318(5856):1535. PubMed ID: 18063761
[No Abstract] [Full Text] [Related]
35. The challenges of quantifying the risk of serious infection with tumor necrosis factor antagonist therapy.
Leombruno J
J Rheumatol; 2010 May; 37(5):887-9. PubMed ID: 20439519
[No Abstract] [Full Text] [Related]
36. Interstitial granulomatous dermatitis associated with the use of tumor necrosis factor alpha inhibitors.
Deng A; Harvey V; Sina B; Strobel D; Badros A; Junkins-Hopkins JM; Samuels A; Oghilikhan M; Gaspari A
Arch Dermatol; 2006 Feb; 142(2):198-202. PubMed ID: 16490847
[TBL] [Abstract][Full Text] [Related]
37. Psoriasiform lesions induced by tumour necrosis factor antagonists: a skin-deep medical conundrum.
Carter JD; Gerard HC; Hudson AP
Ann Rheum Dis; 2008 Aug; 67(8):1181-3. PubMed ID: 18299302
[TBL] [Abstract][Full Text] [Related]
38. Schnitzler's syndrome--exacerbation after anti-TNF treatment.
Thonhofer R; Uitz E; Graninger W
Rheumatology (Oxford); 2007 Jun; 46(6):1041-2. PubMed ID: 17449490
[No Abstract] [Full Text] [Related]
39. Pericardial effusions on anti-TNF therapy for rheumatoid arthritis--a drug side effect or uncontrolled systemic disease?
Edwards MH; Leak AM
Rheumatology (Oxford); 2009 Mar; 48(3):316-7. PubMed ID: 19106166
[No Abstract] [Full Text] [Related]
40. Staphylococcus aureus in patients with rheumatoid arthritis under conventional and anti-tumor necrosis factor-alpha treatment.
Bassetti S; Wasmer S; Hasler P; Vogt T; Nogarth D; Frei R; Widmer AF
J Rheumatol; 2005 Nov; 32(11):2125-9. PubMed ID: 16265689
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
